用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (PHARMACOL

[复制链接]
查看: 29927|回复: 35
发表于 2025-3-21 17:29:17 | 显示全部楼层 |阅读模式
期刊全称JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
期刊简称J OCUL PHARMACOL TH
影响因子20241.963
视频video
ISSN1080-7683
eISSN1557-7732
出版商MARY ANN LIEBERT, INC
发行地址140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
学科分类1.Science Citation Index Expanded (SCIE)--Ophthalmology | Pharmacology & Pharmacy; 2.Biological Abstracts--Ophthalmology | Pharmacology & Pharmacy; 3.BIOSIS Previews_BIOSIS Citation Index--Ophthalmology | Pharmacology & Pharmacy; 4.Current Contents Life Sciences--Medical Research, Organs & Systems; 5.Essential Science Indicators--Pharmacology & Toxicology;
出版语言English
The information of publication is updating

SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)影响因子


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)总引论文


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)总引论文@(药理学与药学)学科排名


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)影响因子


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)总引频次@(药理学与药学)学科排名


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)即时影响因子@(药理学与药学)学科排名


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)五年累积影响因子@(药理学与药学)学科排名


单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:30:45 | 显示全部楼层
发表于 2025-3-22 01:57:31 | 显示全部楼层
Submitted on: 17 August 2022. Revised on: 21 October 2022. Accepted on: 01 December 2022. ___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
发表于 2025-3-22 06:31:59 | 显示全部楼层
Submitted on: 23 March 1999. Revised on: 08 July 1999. Accepted on: 27 July 1999. ___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
发表于 2025-3-22 09:58:56 | 显示全部楼层
Submitted on: 14 March 2008. Revised on: 15 May 2008. Accepted on: 21 June 2008. ___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
发表于 2025-3-22 14:26:27 | 显示全部楼层
Submitted on: 23 March 2011. Revised on: 10 July 2011. Accepted on: 09 August 2011. ___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
发表于 2025-3-22 18:02:30 | 显示全部楼层
发表于 2025-3-23 00:12:39 | 显示全部楼层
Submitted on: 17 October 2002. Revised on: 24 November 2002. Accepted on: 20 December 2002. ___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
发表于 2025-3-23 02:26:37 | 显示全部楼层
发表于 2025-3-23 06:10:49 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 17:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表